4.0 Article

Causal links among amyloid, tau, and neurodegeneration

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease

Amelia Strom et al.

Summary: Posterior cortical hypometabolism measured with F-18-fluorodeoxyglucose (FDG)-PET is a marker of neurodegeneration in Alzheimer's disease, and it is mainly associated with structural neurodegeneration and tau pathology, rather than amyloid pathology.

BRAIN (2022)

Article Cell Biology

The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography

Justin S. Sanchez et al.

Summary: Advances in molecular positron emission tomography have enabled accurate tracking of brain pathology in normal aging and dementia, providing insights into the pathogenesis of Alzheimer's disease. This precise tracking of disease progression is crucial for natural history studies and prevention therapeutic trials.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Differential associations of APOE-epsilon 2 and APOE-epsilon 4 alleles with PET-measured amyloid-beta and tau deposition in older individuals without dementia

Gemma Salvado et al.

Summary: The study found that APOE-ε2 carriers had lower Aβ deposition compared to APOE-ε3 homozygotes, while APOE-ε4 carriers showed significantly increased Aβ and tau deposition.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Geriatrics & Gerontology

Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum

Anna Rubinski et al.

Summary: This study found that tau and amyloid are associated with reduced CBF in patients with Alzheimer's disease, with tau affecting the entorhinal cortex independently of A beta. Additionally, amyloid was associated with lower CBF in temporo-parietal regions. No associations were observed between MRI markers of small vessel disease and CBF.

NEUROBIOLOGY OF AGING (2021)

Article Medicine, General & Internal

Donanemab in Early Alzheimer's Disease

Mark A. Mintun et al.

Summary: In this study, donanemab showed improved composite scores for cognition and daily living activities compared to placebo in patients with early Alzheimer's disease at 76 weeks, although secondary outcomes varied. Longer and larger trials are needed to further explore the efficacy and safety of donanemab in Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Clinical Neurology

Early stages of tau pathology and its associations with functional connectivity, atrophy and memory

David Berron et al.

Summary: The study reveals the progression of tau pathology across subregions within the medial temporal lobe and its specific association with memory performance at different disease stages. In cognitively unimpaired individuals, increased tau load is linked to local atrophy and memory performance, while in mild cognitive impairment patients, the association between hippocampal tau load and memory performance is partially mediated by posterior hippocampal atrophy.

BRAIN (2021)

Article Cell Biology

ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease

Petr Novak et al.

Summary: The study demonstrates that AADvac1, a tau vaccine against Alzheimer's disease, is safe and immunogenic, but no significant clinical efficacy was observed in the whole study sample.

NATURE AGING (2021)

Article Endocrinology & Metabolism

Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging

Murat Bilgel et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)

Article Multidisciplinary Sciences

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease

Nicolai Franzmeier et al.

NATURE COMMUNICATIONS (2020)

Review Clinical Neurology

Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease

Nils Korte et al.

ACTA NEUROPATHOLOGICA (2020)

Article Clinical Neurology

Predicting future rates of tau accumulation on PET

Clifford R. Jack et al.

BRAIN (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

[11C]PIB amyloid quantification: effect of reference region selection

Fiona Heeman et al.

EJNMMI RESEARCH (2020)

Article Multidisciplinary Sciences

Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease

Nicolai Franzmeier et al.

SCIENCE ADVANCES (2020)

Article Geriatrics & Gerontology

Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid

Rachel F. Buckley et al.

NEUROBIOLOGY OF AGING (2019)

Article Clinical Neurology

Longitudinal tau accumulation and atrophy in aging and alzheimer disease

Theresa M. Harrison et al.

ANNALS OF NEUROLOGY (2019)

Article Clinical Neurology

Longitudinal tau PET in ageing and Alzheimer's disease

Clifford R. Jack et al.

BRAIN (2018)

Article Geriatrics & Gerontology

The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype

Olga Pletnikova et al.

NEUROBIOLOGY OF AGING (2018)

Review Clinical Neurology

Resistance vs resilience to Alzheimer disease Clarifying terminology for preclinical studies

Eider M. Arenaza-Urquijo et al.

NEUROLOGY (2018)

Article Multidisciplinary Sciences

Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data

Suzanne L. Baker et al.

DATA IN BRIEF (2017)

Article Clinical Neurology

Fluorodeoxyglucose Metabolism Associated With Tau-Amyloid Interaction Predicts Memory Decline

Bernard J. Hanseeuw et al.

ANNALS OF NEUROLOGY (2017)

Article Neurosciences

Neuronal activity enhances tau propagation and tau pathology in vivo

Jessica W. Wu et al.

NATURE NEUROSCIENCE (2016)

Article Clinical Neurology

Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease

Gerard N. Bischof et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Article Medicine, General & Internal

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis

Willemijn J. Jansen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios

Susan M. Landau et al.

JOURNAL OF NUCLEAR MEDICINE (2015)

Article Cell Biology

Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation

Sara Calafate et al.

CELL REPORTS (2015)

Article Neurosciences

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease

Amy M. Pooler et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)

Article Psychology, Multidisciplinary

Interpretation and Identification of Causal Mediation

Judea Pearl

PSYCHOLOGICAL METHODS (2014)

Article Clinical Neurology

Standardization of analysis sets for reporting results from ADNI MRI data

Bradley T. Wyman et al.

ALZHEIMERS & DEMENTIA (2013)

Article Clinical Neurology

Amyloid-Beta Oligomerization in Alzheimer Dementia versus High-Pathology Controls

Thomas J. Esparza et al.

ANNALS OF NEUROLOGY (2013)

Review Clinical Neurology

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Peter T. Nelson et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

Article Neurosciences

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

Alix de Calignon et al.

NEURON (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease

Benjamin A. Thomas et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Article Geriatrics & Gerontology

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

Susan M. Landau et al.

NEUROBIOLOGY OF AGING (2011)

Article Multidisciplinary Sciences

Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

Ming Jin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Clinical Neurology

Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical characterization

R. C. Petersen et al.

NEUROLOGY (2010)

Article Statistics & Probability

Identification, Inference and Sensitivity Analysis for Causal Mediation Effects

Kosuke Imai et al.

STATISTICAL SCIENCE (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Measurement of MRI scanner performance with the ADNI phantom

Jeffrey L. Gunter et al.

MEDICAL PHYSICS (2009)

Article Neurosciences

Reducing between scanner differences in multi-center PET studies

Aniket Joshi et al.

NEUROIMAGE (2009)

Article Medicine, General & Internal

Mild cognitive impairment as a diagnostic entity

RC Petersen

JOURNAL OF INTERNAL MEDICINE (2004)